methyl (2S,3S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl (2S,3S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
• 化学式: C₁₇H₂₁NO₄
• 分子量: 303.35
• InChiKey: ZPUCINDJVBIVPJ-WUCCLRPBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  methyl (2S,3S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;hydrochloride 、 苯甲酰氯 以56%的产率得到
  参考文献：
  名称：

  CARROLL, F. IVY;LEWIN, ANITA H.;ABRAHAM, PHILIP;PARHAM, KAROL;BOJA, JOHN +, J. MED. CHEM., 34,(1991) N, C. 883-886

  摘要：

  DOI：

文献信息

• MOLECULES THAT STIMULATE THE IMMUNE SYSTEM FOR TREATMENT OF DRUG ADDICTION, METHODS OF SYNTHESIS, ANTIDRUG VACCINE AND USES
  申请人：UNIVERSIDADE FEDERAL DE MINAS GERAIS

  公开号：US20200385376A1

  公开（公告）日：2020-12-10

  This technology relates to immune system stimulating molecules to be used in the treatment of drug addiction and abuse and their synthesis processes. These molecules have a calixarene chemical structure, preferably calix[4]arene and/or calix[8]arene, coupled to an hapten analogous to cocaine, preferably GNE and/or GNC. An anti-drug vaccine, specifically anti-cocaine, is also described using such molecules. The anti-drug vaccine can be also used to prevent fetal exposure to drugs in pregnant women who use drugs and do not wish or cannot stop their use during pregnancy.

  这项技术涉及用于治疗药物成瘾和滥用的免疫系统刺激分子及其合成过程。这些分子具有杯芳烃化学结构，最好是杯[4]芳烃和/或杯[8]芳烃，与类似于可卡因的半抗原偶联，最好是GNE和/或GNC。还描述了使用这种分子的抗药疫苗，特别是抗可卡因。这种抗药疫苗还可用于预防怀孕妇女使用药物但不希望或无法在怀孕期间停止使用时胎儿暴露于药物。
• Technology for the Preparation of Microparticles
  申请人：Malakhov Michael

  公开号：US20090098207A1

  公开（公告）日：2009-04-16

  Microspheres are produced by contacting a solution of a macromolecule or small molecule in a solvent with an antisolvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals, nutraceuticals, cosmetic products and the like of defined dimensions.

  微球是通过将溶液中的大分子或小分子与抗溶剂和对离子接触，并冷却溶液而制备的。这些微球可用于制备具有明确定义尺寸的药物、营养保健品、化妆品等产品。
• Analgesics, anaesthetics, antifoulants, aversants, irritants, incapacitants and compositions containing the same
  申请人：Blum Mel

  公开号：US20070225515A1

  公开（公告）日：2007-09-27

  Compounds and compositions the same. Method of making the compounds. The compounds and/or compositions used as an analgesic, anaesthetic, antifoulant, aversant, irritant, sternutator, neurodegenerator, counter irritant (delayed), rubifaciant, stomachic, fungicide, insecticide, preservative, circulatory stimulant, cardio-protective agent, immune booster, decongestant, anti-inflammatory agent, incapacitant, biocide, mildewcide, pharmaceutical, repellent, flavorant, carminative, antismoking agent, and/or antithrombotic agent. One of the compounds being lidocaine nonivamide. The compositions comprising one or more of: the compounds, one or more of an antioxidant, a UV absorber, and one or more biocides such as, for example, OBPA.

  化合物和组合物相同。制备这些化合物的方法。这些化合物和/或组合物用作止痛剂、麻醉剂、防污剂、驱避剂、刺激剂、喷鼻剂、神经变性剂、延迟性刺激剂、红斑剂、胃药、杀真菌剂、杀虫剂、防腐剂、循环刺激剂、心脏保护剂、免疫增强剂、通窍剂、抗炎剂、致残剂、生物杀灭剂、霉菌杀灭剂、药用、驱虫剂、调味剂、驱风剂、抗吸烟剂和/或抗血栓剂。其中一种化合物是利多卡因辛烷酸酯。组合物包括：这些化合物中的一种或多种、一种或多种抗氧化剂、一种或多种紫外线吸收剂，以及一种或多种生物杀灭剂，例如OBPA。
• Odorless formulation for treating mucosal discontinuities
  申请人：——

  公开号：US20040132810A1

  公开（公告）日：2004-07-08

  The present invention includes a method for making a formulation for treating mucosal discontinuities, comprising: providing phenolic compounds and treating the purified phenolic compounds with sulfuric acid to make sulfonic acids and sulfonate salts. The present invention also includes formulations prepared by the method.

  本发明涉及一种用于制备治疗黏膜不连续的配方的方法，包括：提供酚类化合物，并用硫酸处理纯化的酚类化合物以制备磺酸和磺酸盐。本发明还包括通过该方法制备的配方。
• MEDICAL ADHESIVE FOR SURGERY
  申请人：Heckroth Heike

  公开号：US20110245351A1

  公开（公告）日：2011-10-06

  The invention relates to novel rapidly-curing adhesives made from hydrophilic polyisocyanate prepolymers for application in surgery.

  该发明涉及一种用于手术中的新型快速固化胶粘剂，该胶粘剂由亲水性聚异氰酸酯预聚物制成。